Sadera, Roldan F.

HRN: 00-85-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2024
CEFTRIAXONE 1G (VIAL)
12/10/2024
12/16/2024
IV
2g
Od
Infected Wound, Lip
Waiting Final Action 
12/10/2024
MUPIROCIN 2%, 15G (TUBE)
12/10/2024
12/16/2024
TOPICAL
15g
BID
Infected Wound, Ear
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: